Overall rank by patents
#4,366
Across all tracked assignees
USPTO PatentsView assignee record - 82 granted patents across 24 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04R (LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS).
The verdict
xmems holds 82 US patents across 24 technology areas, rank #4,366 of 50,000 tracked assignees.
Xmems Labs, Inc. has been granted 82 US utility patents between 2019 and 2025, placing Xmems Labs, Inc. at rank #4,366 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.1 claims per patent with primary concentration in H04R (LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS). As a US Corporation, Xmems Labs, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, xmems sits between VAN Cleef & Arpels Sa (82 patents, rank #4,362) and Camelbak Products, Llc (81 patents, rank #4,370) - the closest US assignees by grant volume. The composite Innovation Score of 58.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 78 grants, compared with 4 in the 2015–2019 window, a +1850% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Xmems Labs, Inc.'s 22.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Xmems Labs, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
VAN CLEEF & ARPELS SA
82 patents
YVES SAINT LAURENT
82 patents
aTyr Pharma, Inc.
82 patents
data.world, Inc.
82 patents
xMEMS Labs, Inc.
82 patents
ARPER S.P.A.
81 patents
BSH Bosch und Siemens Hausgeräte GmbH
81 patents
Borealis Technical Limited
81 patents
CAMELBAK PRODUCTS, LLC
81 patents
What this shows Xmems holds 82 patents at rank #4,366, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,366 in granted patent volume.
Other assignees with the most granted patents in Xmems's primary technology class.
xmems's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 4 | 4.9% |
| 2020 | 13 | 15.9% |
| 2021 | 8 | 9.8% |
| 2022 | 17 | 20.7% |
| 2023 | 10 | 12.2% |
| 2024 | 19 | 23.2% |
| 2025 | 11 | 13.4% |
Top 15 of 24 technology areas
Overall rank by patents
#4,366
Across all tracked assignees
58.1 out of 100
How to use this portfolio
xmems's 82 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.